P. Anklesaria

J. Glowacki, J. Greenberger, I. Bleiberg, 1994, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Bone marrow stromal proteoglycan heterogeneity: Phenotypic variability between cell lines and the effects of glucocorticoid

S. Bentley, J. Greenberger, S. Kirby, 1988, Journal of cellular physiology.

Quantitation of murine hematopoietic stem cells in vitro by limiting dilution analysis of cobblestone area formation on a clonal stromal cell line.

J. Greenberger, S. Neben, P. Mauch, 1993, Experimental hematology.

Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study

K. Dao, P. Mease, M. Maricic, 2010, The Journal of Rheumatology.

Differential endocytosis of fluorescein iso-thiocyanate-concanavalin A by normal and chronic myeloid leukemic granulocytes

S. Zingde, A. Bhisey, S. Advani, 1987, Blut.

Expression of p210 bcr/abl increases hematopoietic progenitor cell radiosensitivity.

I. Das, T. Fitzgerald, J. Greenberger, 1993, International journal of radiation oncology, biology, physics.

Two forms of transforming growth factor-β distinguished by multipotential haematopoietic progenitor cells

A. Bassols, J. Massagué, J. Greenberger, 1987, Nature.

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial.

G. Hortobagyi, N. Sneige, V. Valero, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate.

I. Das, T. Fitzgerald, J. Greenberger, 1990, Radiation research.

The v-src oncogene may not be responsible for the increased radioresistance of hematopoietic progenitor cells expressing v-src.

I. Das, T. Fitzgerald, J. Greenberger, 1992, Radiation research.

Safety characterization of HeLa-based cell substrates used in the manufacture of a recombinant adeno-associated virus-HIV vaccine.

C. Gerard, P. Anklesaria, B. Thorne, 2005, Vaccine.

Expression of a selectable gene transferred by a retroviral vector to hematopoietic stem cells and stromal cells in murine continuous bone marrow cultures.

T. Fitzgerald, J. Greenberger, M. Sakakeeny, 1987, Experimental hematology.

Recent studies of the hematopoietic microenvironment in long-term bone marrow cultures

T. Fitzgerald, J. Greenberger, P. Anklesaria, 1989, Immunologic research.

Improved hematopoiesis in anemic Sl/Sld mice by splenectomy and therapeutic transplantation of a hematopoietic microenvironment.

T. Fitzgerald, J. Greenberger, A. Ohara, 1989, Blood.

Recombinant murine GM-CSF increases resistance of some factor dependent hematopoietic progenitor cells to low-dose-rate gamma irradiation.

T. Fitzgerald, J. Greenberger, M. Santucci, 1989, International journal of radiation oncology, biology, physics.

Cell-cell adhesion mediated by binding of membrane-anchored transforming growth factor alpha to epidermal growth factor receptors promotes cell proliferation.

J. Massagué, M. Laiho, J. Greenberger, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Gamma-irradiation response of cocultivated bone marrow stromal cell lines of differing intrinsic radiosensitivity.

B. Woda, T. Fitzgerald, J. Greenberger, 1990, International journal of radiation oncology, biology, physics.

Enhancer sequences of a retroviral vector determine expression of a gene in multipotent hematopoietic progenitors and committed erythroid cells.

J. Greenberger, M. Sakakeeny, P. Anklesaria, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Redox modifier genes and pathways in amyotrophic lateral sclerosis.

J. Engelhardt, B. Carter, Stephanie Choi, 2009, Antioxidants & redox signaling.

Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study

E. Keystone, P. Mease, K. Hobbs, 2008, Annals of the rheumatic diseases.

A multicenter phase II study of tgDCC‐E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma

M. Hung, D. Villaret, G. Yoo, 2002, Head & neck.

Retroviral src gene expression in continuous marrow culture increases the self-renewal capacity of multilineage hematopoietic stem cells.

J. Pierce, J. Greenberger, A. Ohara, 1989, Leukemia.

Studies on Granulocyte Functions in Patients with Chronic Myeloid Leukemia

A. Bhisey, S. Advani, P. Anklesaria, 1985, Tumori.

Interaction between x-irradiated plateau-phase bone marrow stromal cell lines and co-cultivated factor-dependent cell lines leading to leukemogenesis in vitro.

T. Fitzgerald, J. Greenberger, M. Sakakeeny, 1987, Scanning microscopy.

Calculating expected lung deposition of aerosolized administration of AAV vector in human clinical studies

A. Coates, K. Munson, P. Anklesaria, 2007, The journal of gene medicine.

In vivo efficacy of folate-targeted lipid–protamine–DNA (LPD-PEG-Folate) complexes in an immunocompetent syngeneic model for breast adenocarcinoma

E. Bruckheimer, P. Harvie, P. Anklesaria, 2004, Cancer Gene Therapy.

Experimental Medicine for HIV Vaccine Research and Development

S. Buchbinder, L. Bekker, R. Shattock, 2023, Vaccines.

Hemonectin mediates adhesion of engrafted murine progenitors to a clonal bone marrow stromal cell line from Sl/Sld mice.

M. Wicha, T. Fitzgerald, J. Greenberger, 1991, Blood.

A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.

Philip R. Johnson, S. Kochhar, J. van Lunzen, 2008, AIDS research and human retroviruses.

A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus.

Philip R. Johnson, P. Kaleebu, L. Bekker, 2010, AIDS research and human retroviruses.

Eighth International Conference on Gene Therapy of Cancer

H. Engler, B. Hutchins, S. Wen, 1999, Cancer Gene Therapy.

Gene therapy: a molecular approach to cancer treatment.

P. Anklesaria, 2000, Current opinion in molecular therapeutics (Print).

Single-joint Outcome Measures: Preliminary Validation of Patient-reported Outcomes and Physical Examination

P. Mease, A. Heald, P. Anklesaria, 2010, The Journal of Rheumatology.

1092. Clinical Studies of Intra_Articular Administration of a Recombinant Adeno_Associated Vector Containing a TNF_α Antagonist Gene in Inflammatory Arthritis

A. Heald, P. Anklesaria, G. Pate, 2006 .

Alteration in hematopoietic stem cell seeding and proliferation by both high and low dose rate irradiation of bone marrow stromal cells in vitro.

T. Fitzgerald, J. Greenberger, M. Sakakeeny, 1988, International journal of radiation oncology, biology, physics.

Redox modifier genes and pathways in amyotrophic lateral sclerosis.

J. Engelhardt, B. Carter, Stephanie Choi, 2009, Antioxidants & redox signaling.

Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study

E. Keystone, P. Mease, P. Anklesaria, 2008, Annals of the rheumatic diseases.

Biochemical and functional characterization of proteoglycans produced by SI/SId murine bone marrow stromal cell lines

S. Bentley, J. Greenberger, S. Kirby, 1990, Journal of cellular physiology.

A new X-linked variant of chronic granulomatous disease characterized by the existence of a normal clone of respiratory burst-competent phagocytic cells.

P. Newburger, M. Cohen, J. Rae, 1995, Blood.